📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: AnovoRx

1.1 - Company Overview

AnovoRx Logo

AnovoRx

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmacy and access services for ultra-rare medications, offering 3PL/specialty distribution, patient support (benefits investigation, prior authorization and appeals, case management), reimbursement programs, clinical assessment and adherence management, adverse event reporting, and product complaint and recall management.

Products and services

  • Specialty Pharmacy Patient Management: Delivers clinical-grade oversight with clinical assessments, patient adherence programs, and adverse event reporting coordinated by dedicated pharmacy teams for ultra-rare therapies
  • Patient Support Services: Custom-engineered assistance including benefits investigation, prior authorization support, appeal support, and patient case management to streamline access to ultra-rare medications
  • 3PL/Specialty Wholesale Distributor: Enterprise-grade distribution engineered through an exclusive specialty pharmacy model to manage products and eliminate nationwide licensure requirements.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to AnovoRx

Clinical Trial Data Logo

Clinical Trial Data

HQ: United States Website
  • Description: Provider of data management, biostatistical, and medical writing services for pharmaceutical companies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Clinical Trial Data company profile →
Amatsigroup Logo

Amatsigroup

HQ: France Website
  • Description: Provider of GLP- and GMP-compliant CRO/CMO services for human and veterinary pharmaceutical product development, leveraging the expertise of renowned CROs/CMOs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amatsigroup company profile →
Endeavor Clinical Trials Logo

Endeavor Clinical Trials

HQ: United States Website
  • Description: Provider of research and clinical trials specializing in surgical, orthopedic, and specialty medicine, based in San Antonio, Texas, with over 20 years of experience; one of 8 portfolio research units.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Endeavor Clinical Trials company profile →
Acurian Logo

Acurian

HQ: United States Website
  • Description: Provider of patient and doctor recruitment, enrollment and retention solutions for clinical trials, including recruitment feasibility, site identification and selection, data-driven patient recruitment, an integrated network for AES research sites, geo-targeted vaccine volunteer enrollment via a global site network, specialized strategies for challenging indications (Alzheimer's, NASH), and cancer solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acurian company profile →
ZenBio Logo

ZenBio

HQ: United States Website
  • Description: Provider of human cell-based research products and contract research services, including preadipocytes and adipocytes for drug screening and development; cell-based assay development and custom consultations; individualized cell-based or biochemical screening programs; cell characterization and molecular biology services; and ready-to-use visceral preadipocyte and adipocyte media.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ZenBio company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for AnovoRx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to AnovoRx

2.2 - Growth funds investing in similar companies to AnovoRx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for AnovoRx

4.2 - Public trading comparable groups for AnovoRx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to AnovoRx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About AnovoRx

What does AnovoRx do?

AnovoRx is a provider of specialty pharmacy and access services for ultra-rare medications, offering 3PL/specialty distribution, patient support (benefits investigation, prior authorization and appeals, case management), reimbursement programs, clinical assessment and adherence management, adverse event reporting, and product complaint and recall management.

Who are AnovoRx's competitors?

AnovoRx's competitors and similar companies include Clinical Trial Data, Amatsigroup, Endeavor Clinical Trials, Acurian, and ZenBio.

Where is AnovoRx headquartered?

AnovoRx is headquartered in United States.

How many employees does AnovoRx have?

AnovoRx has 1,000 employees 🔒.

When was AnovoRx founded?

AnovoRx was founded in 2010 🔒.

What sector and industry vertical is AnovoRx in?

AnovoRx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for AnovoRx

Who are the top strategic acquirers in AnovoRx's sector and industry

Top strategic M&A buyers and acquirers in AnovoRx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for AnovoRx?

Top strategic M&A buyers groups and sectors for AnovoRx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in AnovoRx's sector and industry vertical

Which are the top PE firms investing in AnovoRx's sector and industry vertical?

Top PE firms investing in AnovoRx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in AnovoRx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in AnovoRx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in AnovoRx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to AnovoRx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in AnovoRx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for AnovoRx?

The key public trading comparables and valuation benchmarks for AnovoRx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for AnovoRx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for AnovoRx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in AnovoRx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for AnovoRx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in AnovoRx's' sector and industry vertical?

Access recent funding rounds and capital raises in AnovoRx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for AnovoRx